![Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Recommendation of "Hold" from Analysts - MarketBeat Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Recommendation of "Hold" from Analysts - MarketBeat](https://www.marketbeat.com/logos/Gilead_Sciences_Pty_Ltd-1200x675.jpg)
Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Gilead quarterly revenue drops 4%, oral COVID drug fails trial -February 07, 2024 at 02:33 am IST | MarketScreener
![How Gilead Paid $12 Billion For $30 Million In Revenue And Thinks To Make A Profit (NASDAQ:GILD) | Seeking Alpha How Gilead Paid $12 Billion For $30 Million In Revenue And Thinks To Make A Profit (NASDAQ:GILD) | Seeking Alpha](https://static.seekingalpha.com/uploads/2017/8/30/saupload_fed07b8b43ddb80ce67e06ebad896295.png)
How Gilead Paid $12 Billion For $30 Million In Revenue And Thinks To Make A Profit (NASDAQ:GILD) | Seeking Alpha
![Why Gilead Sciences Inc Stock Is A Buy? Acquirer's Multiple Stock Screener Analysis | The Acquirer's Multiple® Why Gilead Sciences Inc Stock Is A Buy? Acquirer's Multiple Stock Screener Analysis | The Acquirer's Multiple®](https://media.ycharts.com/charts/59e57804c5d3e4255d13fe1d28ca3e98.png)
Why Gilead Sciences Inc Stock Is A Buy? Acquirer's Multiple Stock Screener Analysis | The Acquirer's Multiple®
![Why Gilead Sciences Inc Stock Is A Buy? Acquirer's Multiple Stock Screener Analysis | The Acquirer's Multiple® Why Gilead Sciences Inc Stock Is A Buy? Acquirer's Multiple Stock Screener Analysis | The Acquirer's Multiple®](https://acquirersmultiple.com/wp-content/uploads/2023/09/gild.jpeg)